发明申请
US20160331831A1 LENTIVIRAL VECTORS FOR GENERATING IMMUNE RESPONSES AGAINST HUMAN T LYMPHOTROPHIC VIRUS TYPE 1 有权
用于产生人类淋巴瘤病毒1型免疫应答的生殖细胞

  • 专利标题: LENTIVIRAL VECTORS FOR GENERATING IMMUNE RESPONSES AGAINST HUMAN T LYMPHOTROPHIC VIRUS TYPE 1
  • 专利标题(中): 用于产生人类淋巴瘤病毒1型免疫应答的生殖细胞
  • 申请号: US15112854
    申请日: 2015-01-27
  • 公开(公告)号: US20160331831A1
    公开(公告)日: 2016-11-17
  • 发明人: Deborah RevaudCecile Bauche
  • 申请人: THERAVECTYS
  • 优先权: EP14290009.1 20140127
  • 国际申请: PCT/IB2015/050598 WO 20150127
  • 主分类号: A61K39/21
  • IPC分类号: A61K39/21 C12N7/00 C12N15/86 C07K14/005
LENTIVIRAL VECTORS FOR GENERATING IMMUNE RESPONSES AGAINST HUMAN T LYMPHOTROPHIC VIRUS TYPE 1
摘要:
The present invention relates to compositions, methods, and uses employing lentiviral vector particles for induction of an immune response by administration to a human, wherein the lentiviral vector particles comprise a lentiviral vector, wherein the DNA of the lentiviral vector comprises a promoter directing expression of an HTLV-1 Tax and/or HBZ antigen, and/or a p12I and/or p30II antigen. The invention encompasses these vectors, methods of making the vectors, and methods of using them, including medicinal uses.
信息查询
0/0